National Cancer Center Korea
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1989-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.ncc.re.kr
Neoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR Mutations
- First Posted Date
- 2011-11-11
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 26
- Registration Number
- NCT01470716
- Locations
- 🇰🇷
National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer
Phase 2
- Conditions
- Small Cell Lung Carcinoma
- Interventions
- Drug: IP chemotherapyDrug: IP chemotherapy plus simvastatin
- First Posted Date
- 2011-09-27
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 192
- Registration Number
- NCT01441349
- Locations
- 🇰🇷
National Cancer Center , Korea, Goyang-si, Gyeonggi-do, Korea, Republic of
Ultrasound Guided Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Colonic Resection
Phase 3
Completed
- Conditions
- Laparoscopic Colecctomy
- Interventions
- First Posted Date
- 2011-08-25
- Last Posted Date
- 2012-08-06
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 56
- Registration Number
- NCT01423292
- Locations
- 🇰🇷
National Cancer Center, Goyang, Gyeonggi-do, Korea, Republic of
Combined Application of EBUS and EUS in Lung Cancer
Not Applicable
Completed
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- Procedure: EBUS-TBNA followed by EUS-B-FNAProcedure: EUS-B-FNA followed by EBUS-TBNA
- First Posted Date
- 2011-06-29
- Last Posted Date
- 2012-10-18
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 162
- Registration Number
- NCT01385111
- Locations
- 🇰🇷
National Cancer Center (NCC) Korea, Goyang, Gyeonggi-do, Korea, Republic of
Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.
- First Posted Date
- 2011-06-27
- Last Posted Date
- 2014-09-25
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 35
- Registration Number
- NCT01380275
- Locations
- 🇰🇷
National Cancer Center, Goyang-si, Gyeonggi, Korea, Republic of
Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients
Completed
- Conditions
- TuberculosisEarly Gastric CancerTuberculosis, Pulmonary
- Interventions
- Drug: standard first line anti-TB drugs
- First Posted Date
- 2011-06-02
- Last Posted Date
- 2020-09-25
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 40
- Registration Number
- NCT01364324
- Locations
- 🇰🇷
Respiratory Clinic, National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic Carcinoma
Phase 2
Terminated
- Conditions
- Resectable Pancreatic Carcinoma
- Interventions
- Radiation: chemoradiotherapy with Gemcitabine
- First Posted Date
- 2011-04-11
- Last Posted Date
- 2020-04-06
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 23
- Registration Number
- NCT01333124
- Locations
- 🇰🇷
National Cancer Center, Korea, Goyang-si, Gyeonggi-do, Korea, Republic of
Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL)
Phase 2
- Conditions
- Hodgkin's Lymphoma
- Interventions
- Drug: Oxaliplatin-based chemotherapy (ESHAOx)
- First Posted Date
- 2011-02-21
- Last Posted Date
- 2011-02-21
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 37
- Registration Number
- NCT01300156
- Locations
- 🇰🇷
National Cancer Center, Korea, Goyang, Korea, Republic of
Efficacy of Single Incision (Embryonic NOTES) Laparoscopic Colorectal Surgery
Phase 2
Completed
- Conditions
- Colorectal Cancer
- Interventions
- Procedure: Single Incision Laparoscopic Surgery
- First Posted Date
- 2011-01-04
- Last Posted Date
- 2012-08-06
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 48
- Registration Number
- NCT01269060
- Locations
- 🇰🇷
National Cancer Center Hospital, Goyang, Gyeonggi-do, Korea, Republic of
The Efficacy of Health Navigation® for Cancer-Related Fatigue in Cancer Survivors
Phase 2
- Conditions
- Cancer-related Fatigue
- Interventions
- Behavioral: Tailored web-based care program (Health Navigation®)
- First Posted Date
- 2010-10-27
- Last Posted Date
- 2010-10-27
- Lead Sponsor
- National Cancer Center, Korea
- Target Recruit Count
- 266
- Registration Number
- NCT01228773
- Locations
- 🇰🇷
National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath